Lifebit Federated Research & Discovery

by Lifebit  · Based in United Kingdom →Federate & Discover Everything. Move Nothing.
Laboratory Medicine Oncology Pathology

Contact for pricing

Overview

Lifebit Federated Research & Discovery is an AI-powered platform designed for secure biomedical data analysis. It functions as a Trusted Research Environment (TRE), enabling researchers to generate insights from distributed datasets without moving the data from its original location. This approach aims to enhance data security and compliance with data governance regulations.

This tool is intended for use by various healthcare and research entities, including government health initiatives, commercial pharmaceutical companies, health systems, and data providers. It supports specialties and care settings involved in genomics, precision medicine, and clinical research.

Within a clinical or practice workflow, Lifebit Federated Research & Discovery facilitates the entire research lifecycle. This includes data exploration, harmonization, cohort creation, in-depth analysis, and secure sharing of insights. Physicians and researchers can leverage it for tasks such as patient registries, clinical interpretation, biomarker discovery, target validation, and surveillance of adverse drug reactions and disease outbreaks.

Notable capabilities include its federated architecture, which allows for analysis of diverse, globally distributed datasets while maintaining data sovereignty. The platform supports various analysis modalities, from interactive environments to large-scale batch pipelines. It also features an AI-driven interface that allows researchers to perform tasks using natural language, aiming to simplify data harmonization, cohort identification, and analysis.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Federated Trusted Research Environment (TRE)
  • AI-powered data harmonization and standardization (OMOP, FHIR, GA4GH)
  • Secure, in-place analysis of distributed data
  • AI-driven querying with natural language processing
  • Airlock for secure and compliant data export
  • Full auditability and access controls
  • Intuitive cohort building and visualization
  • Support for multi-omics and clinical data
  • Scalable cloud and hybrid infrastructure deployment
  • Real-time drug side effects and disease outbreak surveillance (Lifebit R.E.A.L.)

Use Cases

  • Accelerating drug discovery and therapeutic development
  • Enhancing clinical interpretation and patient stratification
  • Enabling population-scale genomics research
  • Biomarker discovery and target validation
  • Real-time surveillance of adverse drug reactions and disease outbreaks
  • Optimizing clinical trials

What Physicians Need to Know

Molecule Screening Capability
While not explicitly detailed as 'molecule screening,' Lifebit's platform supports AI-powered genomics and multi-omics analysis for target identification and biomarker discovery, which are foundational steps in drug discovery that can inform molecule screening efforts.
Clinical Trial Matching
Lifebit enables more efficient digital clinical trial recruitment through federated data analysis and secure patient matching systems. It allows pre-screening against harmonized EHR cohorts and uses privacy-preserving record linkage to track candidates without exposing identifiers.
Real-World Evidence Analysis
The platform facilitates real-time evidence generation by analyzing diverse datasets, including EHRs and genomics, without moving the data. Lifebit R.E.A.L. (Real-time drug side effects and disease outbreak surveillance) is a key component for real-time pharmacovigilance and AI-powered evidence generation.
Genomic Data Integration
Lifebit's Federated Platform is purpose-built for precision medicine, harnessing multi-modal and multi-omic data. It connects and harmonizes NGS data across sources, unifying genomic, transcriptomic, and clinical datasets to standards like OMOP, FHIR, and GA4GH.
Literature Mining
The provided information does not explicitly detail literature mining capabilities within the Lifebit Federated Research & Discovery platform.
Target Identification
Lifebit offers a 'Trusted TargetID' suite that streamlines drug target identification with AI-powered genomics and multi-omics analysis. It supports large-scale genome-wide association studies (GWAS) to uncover key variants linked to disease.
Safety Signal Detection
Lifebit R.E.A.L. provides real-time drug side effect and disease outbreak surveillance. The platform uses AI for pharmacovigilance to automate adverse event detection, accelerate signal detection, and enable real-time monitoring across diverse data sources.
Collaboration Features
The platform is designed for secure, federated collaboration, allowing joint analysis and validation across global data sources with built-in privacy preservation. It enables researchers to share data, results, and code access with team members without moving sensitive data.
Publication Support
Lifebit's platform supports the entire research lifecycle, from study design to publication, by providing a specialized digital workspace for scientists to share data, manage projects, analyze results, and publish findings while maintaining security and compliance.
Physician Tip

For physicians involved in research, Lifebit Federated Research & Discovery offers a secure environment to leverage vast, distributed biomedical data for insights without compromising patient privacy. Utilize the platform's cohort building and querying tools to identify suitable patient populations for clinical trials and real-world evidence studies. The AI-powered target identification and biomarker discovery features can help in understanding disease mechanisms and potential therapeutic avenues. Engage with the collaboration features to participate in multi-institutional studies, contributing to broader scientific advancements while ensuring data governance and compliance. The real-time safety signal detection capabilities can also provide valuable insights into drug safety profiles.

Lifebit's Federated Platform embraces open source, open standards, and an integration-first approach, offering flexibility for various analytics use cases. It harmonizes data to industry best practices like OMOP, FHIR, and GA4GH standards, ensuring interoperability. The platform provides a full analytics stack including JupyterLab, RStudio, Spark, and allows users to bring and run their own Nextflow pipelines, containerized tools, or web applications. It also integrates with external solutions across diverse architectures.

Details

Category Drug Discovery & Research, Population Health Analytics
Pricing Contact for pricing
DeploymentCloud-based, Hybrid (HPC-Cloud)
Compliance
BAA Available Yes AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated
Integrations
EHR Not specified
Specialties Laboratory Medicine, Oncology, Pathology

What the Web Says

Lifebit Federated Research & Discovery is a platform designed to accelerate healthcare discoveries by enabling secure and compliant analysis of distributed biomedical data, including genomics and real-world evidence. It utilizes a federated lakehouse architecture and AI capabilities to allow researchers to analyze data where it resides, without moving it, addressing concerns around data silos, privacy, and regulatory compliance.

Overall: Positive

Strengths

  • Enables secure and compliant analysis of sensitive biomedical data without moving it, addressing privacy concerns (e.g., HIPAA, GDPR, FedRAMP).
  • Accelerates drug discovery and clinical research by breaking down data silos and enabling collaboration across distributed datasets.
  • Leverages AI and machine learning for advanced analytics, identifying patterns, predicting outcomes, and automating data review.
  • Provides a Trusted Research Environment (TRE) with robust security features, access controls, and audit trails.
  • Supports various data types (genomic, clinical, multi-omics) and harmonizes them to industry best practices (e.g., OMOP, GA4GH, FHIR).
  • Offers scalability and interoperability, with deployment options on major cloud providers like AWS, Azure, and GCP.

Limitations

  • Limited independent reviews from physicians, healthcare IT professionals, or tech reviewers on platforms like G2, Capterra, or Reddit.
  • Some general concerns about the potential for bias in reviews on platforms like Capterra, though not specific to Lifebit.
  • The complexity of managing on-premise HPC clusters when migrating to cloud solutions for bioinformatics, though Lifebit aims to simplify this.
  • The challenge of harmonizing disparate data from multiple sources, even with tools designed to address it.

Based on reviews from: Microsoft Marketplace, Lifebit Biotech (via blog posts and articles featuring their CEO), FirstWord HealthTech, Digital Marketplace (UK Government), AWS Marketplace, EIN News, Reddit (r/bioinformatics), The Journal of Precision Medicine

Last updated: 2026-07-04

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Lifebit Federated Research & Discovery

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Genomics England
Lifebit and Genomics England Partner to Launch New Research Environment
Lifebit and Genomics England have partnered to launch a new federated research environment, enabling secure and ethical analysis of genomic and health data for researchers. This collaboration aims to accelerate discoveries in precision medicine.
2023-11
UK Tech News
Lifebit Secures u00a360M Series B Funding to Accelerate Global Expansion of Federated Research Platform
Lifebit has successfully raised u00a360 million in Series B funding to expand its federated research platform globally, aiming to democratize access to biomedical data for drug discovery and development. The funding will support the company's growth and technological advancements.
2023-10
Lifebit
Lifebit and Boehringer Ingelheim Collaborate on Federated Data Analysis for Drug Discovery
Lifebit has announced a collaboration with Boehringer Ingelheim to leverage its federated research platform for secure and efficient analysis of sensitive R&D data, accelerating drug discovery efforts. This partnership highlights the growing adoption of federated learning in pharmaceutical research.
2023-09
Nature Medicine
The Promise of Federated Learning in Healthcare Research
This article discusses the transformative potential of federated learning in healthcare research, highlighting how platforms like Lifebit's enable secure, privacy-preserving analysis of distributed datasets. It emphasizes the benefits for collaborative research and the development of new treatments.
2023-08
Lifebit
Lifebit's Federated Research Platform Selected by Hong Kong Genome Institute
The Hong Kong Genome Institute has chosen Lifebit's federated research platform to establish a secure and scalable environment for genomic data analysis, facilitating advanced research and precision medicine initiatives. This adoption underscores the platform's global reach and impact.
2023-07
Forbes
How Federated Learning is Revolutionizing Drug Discovery
This Forbes article explores how federated learning, exemplified by platforms like Lifebit's, is transforming drug discovery by enabling secure analysis of decentralized data without compromising patient privacy. It discusses the efficiency and ethical advantages of this approach.
2023-06
NIHR
Lifebit Partners with NIHR BioResource to Enhance Genomic Research
Lifebit has partnered with the NIHR BioResource to provide a federated data analysis platform, aiming to accelerate research into rare diseases and common health conditions. This collaboration will enhance researchers' ability to securely access and analyze valuable genomic data.
2023-05
HealthIT.gov
The Regulatory Landscape of Federated Data Sharing in Healthcare
This article from HealthIT.gov examines the evolving regulatory considerations for federated data sharing in healthcare, discussing frameworks and guidelines relevant to platforms like Lifebit's. It highlights the importance of compliance for secure and ethical data utilization.
2023-04

Videos

Product demos, reviews, and walkthroughs for Lifebit Federated Research & Discovery.

Loading videos...

View all on YouTube

Frequently Asked Questions

Lifebit Federated Research & Discovery utilizes a federated learning approach, meaning that patient data never leaves the secure environment of your institution. Instead, the analytical algorithms travel to the data, process it locally, and only aggregated, anonymized results are shared, ensuring robust data privacy and security compliance with regulations like GDPR and HIPAA.
Lifebit's platform is designed to support compliance with stringent data governance and ethical guidelines. Your institution maintains full control over patient data, and the platform facilitates adherence to consent protocols by ensuring only authorized and ethically approved analyses are conducted on de-identified or anonymized datasets within your secure environment.
Lifebit Federated Research & Discovery enables a wide range of research, from identifying novel drug targets and biomarkers to understanding disease progression and patient stratification for clinical trials. By allowing researchers to analyze vast, diverse datasets without centralizing sensitive information, it significantly accelerates the identification of insights crucial for developing new therapies.
While other federated learning platforms exist, Lifebit differentiates itself through its focus on biomedical data, its comprehensive suite of analytics tools, and its established network of research institutions. The platform is specifically tailored for complex genomic and clinical data analysis, offering a user-friendly interface for researchers without extensive bioinformatics expertise.
While powerful, limitations can include the initial setup and integration with existing institutional IT infrastructure. The complexity of analyses might also be constrained by the computational resources available at each participating site, though Lifebit continuously works to optimize performance and expand data type compatibility.
Pricing for Lifebit Federated Research & Discovery is typically structured based on institutional needs, often involving licensing fees that may vary depending on the scale of deployment, the number of users, and the specific modules or features required. Detailed pricing models are usually discussed directly with interested institutions to tailor a solution.

Related Tools

Noodle Biomedical Literature Discovery
Helena Bioinformatics
Drug Discovery & Research
Noodle is a biomedical literature discovery platform that allows researchers to search publications by meaning, inspect paper details, and explore related evidence through citation connections and semantic neighborhoods. It offers a public read-only Model Context Protocol (MCP) interface for AI agents.
Trially AI
Trially AI
Drug Discovery & Research
Trially's HIPAA-compliant AI platform matches, engages, and enrolls patients into trials with high accuracy, built for physicians and research sites.
Trial Library
Trial Library
Drug Discovery & Research
Trial Library's AI-native platform is embedded in community oncology practices to identify eligible patients for oncology clinical trials. It integrates clinical trials into routine care, activating providers, identifying eligible patients, and navigating them through the trial lifecycle across health systems, biopharma, and payers.
Mendel.ai
Mendel.ai
Clinical Decision Support & Reference
Mendel.ai uses Neuro-Symbolic AI to sort patient cohorts from EHRs for clinical trial matching, accelerating research.
Haystack Enroll
Haystack Health
Drug Discovery & Research
Haystack Health is a clinical trial platform that utilizes AI and care navigation to connect health plan members and ACO patients with relevant clinical trials, aiming to expand treatment access and improve outcomes.
Dyania Health Clinical Trial Recruitment
Dyania Health
Drug Discovery & Research
Dyania Health's AI-powered software automates patient identification from EHRs for clinical trial recruitment, serving hospitals, health systems, and pharmaceutical companies.

See all Drug Discovery & Research tools →

Suggest an Edit → | Last Verified: 2026-07-03 | First Added: 2026-07-03

Investors who backed Lifebit Federated Research & Discovery

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.